No photo of Christopher Mark Moore

View Scopus Profile

Christopher Mark Moore

  • 181 Citations
20042019
If you made any changes in Pure, your changes will be visible here soon.

Grants 2014 2015

Finished

Prot #RNLC2131: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects with Early Decompensated

Moore, C. M.

Salix Pharmaceuticals, Inc.

9/29/14 → 12/31/15

Project: Research project